BioSpace News Archive

Rite Aid has deepened its bench of health industry leaders with the appointment of two new executives: Roxanne Schwans has joined the company to lead market access and pharmacy purchasing, and Chris Bohrer has joined to build out Rite Aid’s health plan solutions business and strategic initiatives.

Utah Medical Products, Inc. announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents per share of common stock payable on October 5, 2020 to shareholders of record at the close of business on September 15, 2020.

Life Spine Announces FDA 510(k) Clearance for the PLATEAU ® -X Ti Lateral Lumbar Spacer System

Chrysalis BioTherapeutics, Inc., a clinical-stage biotechnology company developing regenerative drugs that target vascular endothelial and progenitor cells, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has provided additional funding in the amount of $587,995 to its contract with Chrysalis, bringing the total contract award to de

As part of the company’s Software Upgrades for Life program, the upgrade will be deployed to all installed U.S. molecular imaging systems at no additional cost to customers.

Today, Bristol Myers Squibb Canada (BMS) announces Health Canada’s approval of OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab) with two cycles of platinum-double chemotherapy for the treatment of patients with metastatic non-small cell lung cancer (NSCLC)

Biocom, the association representing the California life science industry, announced the appointment of Randy Piper as managing director for the Biocom Purchasing Group, a subsidiary of Biocom that accelerates life science success by leveraging innovative, member-driven strategic sourcing solutions that significantly lower the total cost of doing business.

Orphan Drug Designation (ODD) is a status that provides seven years of additional post-approval protection and exemption from filing fees Rare Pediatric Disease Designation (RPDD) qualifies the sponsor at the time of registration for a salable, transferable priority review voucher which can be used to speed up the approval process for another drug candidate

Confluent Medical Technologies, a global leader in contract manufacturing of specialized medical devices, announced the opening of its new Complex Catheter Design and Development Center in Austin, Texas.

Queset Medical, Inc.,(https://quesetmedical.com/) a leading distributor of supplies for pulmonary function testing, has a complete line of PFT Anti-Viral filters that comply with recent guidance for spirometry testing during the Corona Virus pandemic.